Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
16 Leser
Artikel bewerten:
(0)

Dr. Martin Schreiber Joins DaVita Kidney Care Team

DENVER, July 9, 2014 /PRNewswire-USNewswire/ --DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced that the company has named Martin Schreiber, M.D., as its new vice president of clinical affairs for home modalities.

DaVita logo.

DaVita's home hemodialysis (HHD) and peritoneal dialysis (PD) programs currently serve more patients than any other HHD or PD program in the United States.

"I believe that every patient deserves to be educated on their modality options and to have a choice in their dialysis care," said Dr. Schreiber. "While home dialysis may not be right for everyone, we recognize that many patients could benefit from more frequent dialysis and enjoy a higher quality of life with the option of a home modality."

With nearly 40 years of experience in nephrology, Dr. Schreiber has worked primarily with Cleveland Clinic and held a number of key positions there, including chairman of the Department of Nephrology and Hypertension and the director of home dialysis. Additionally, he is an active educator and international lecturer with ongoing editorial responsibilities with the Journal of the American Society of Nephrology, American Journal of Kidney Disease and Peritoneal Dialysis International.

"DaVita's mission is to be the provider and partner of choice," said DaVita Kidney Care CEO Javier Rodriguez. "To achieve this mission, we recruit top clinical leaders, like Dr. Schreiber. His commitment to continuous improvement in kidney care and role as an advocate for home dialysis are a great fit for the DaVita Village."

"Dr. Schreiber has been a leader in nephrology and patient-centric kidney care for over two decades," said DaVita Kidney Care's Chief Medical Officer Allen R. Nissenson, M.D. "His experience, compassion, and understanding of the needs of patients and physicians make him a unique and outstanding additional to DaVita's physician leadership team."

DaVita's home dialysis program boasts innovation in PD fluid management protocols, as well as in PD and HHD patient training. On average, patients in DaVita's PD program experience peritonitis less than once every four years. The program also hosts recurring, company-wide patient modality education initiatives.

AboutDaVita Kidney Care
DaVita Kidney Careis a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Caretreats patients with chronic kidney failure and end stage renal disease.DaVita Kidney Carestrives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of March 31, 2014,DaVita Kidney Careoperated or provided administrative services at 2,098 outpatient dialysis centers located in the United States serving approximately 165,000patients. The company also operated 75 outpatient dialysis centers located in 10 countries outside the United States.DaVita Kidney Caresupports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visitDaVita.com.

Contact Information
Media:
Bianca Violante
Bianca.Violante@davita.com
(303) 876-6614

Logo - http://photos.prnewswire.com/prnh/20140303/LA75036LOGO-b

SOURCE DaVita Inc.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.